GL1X · GenesisL1 explorer

MolNFT v1 · #167680 · protein

JAK2 JH1 in complex with BL2-057

6VS3 · Tyrosine-protein kinase JAK2: “JAK2 JH1 in complex with BL2-057”. X-ray diffraction, 1 ligand (R6V), 4 pockets (best druggability 0.75). MolNFT v1 #167680 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6VS3
Type
protein
Length
587 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
R6V
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28944% helix, 20% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29843% helix, 21% strandO60674

Ligands and binding sites

  • R6V · (3R)-3-cyclopentyl-3-[4-(2-{[4-(piperidin-4-yl) phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17000.750.8169empty
24450.730.8356R6V
34840.700.8060R6V
4580.320.7716empty

Interfaces

1 interface between chains.

  • A–B · 509 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 6VS3 · JAK2 JH1 in complex with BL2-057 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.